Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Lineage's Chief Executive ...

(TSVT) stock lost as company with Bristol Myers Squibb (BMY) plan to discontinue enrollments in a Phase 3 trial for cancer ...

2seventy bio and Bristol Myers Squibb are pulling the plug on a late-stage study of their Abecma gene therapy in certain people newly diagnosed with the blood cancer multiple myeloma.

Abecma, developed in partnership with Bristol-Myers Squibb, for treating patients with newly diagnosed multiple myeloma.

Ananda Labs is developing novel solutions for aging-related conditions from wrinkles, to scars to a more youthful immune ...

Some people would say that the ailment is a spiritual problem or foisted on their child by negative forces. This is a myth ...

A 68-year-old African American woman from Flint who suffers from leukemia is one of the first people in the world to ever ...

On Tuesday, Zac Efron opened up about his journey with stem cell therapy following his training for A-24’s The Iron Claw film ...

A team at the Hübner and Diecke Labs at the Max Delbrück Center has shown how human and non-human primate hearts differ ...

The Children's Hospital of Michigan has started offering gene therapy for beta thalassemia and plans to treat sickle cell ...

The company has not yet seen the financial payoff from its scientific breakthroughs — and it says it is continuing to lose ...

Children's Hospital of Michigan is treating the first person in Michigan with a newly approved gene-editing therapy for beta thalassemia.